Lantern Pharma Inc. Restricted Cash, Current
Lantern Pharma Inc. (LTRN) had Restricted Cash, Current of $541.18 thousand as of 2023-06-30, per its 10-Q filed 2023-08-09.
Discontinued › Balance Sheet › Assets › Assets, Current › Restricted Cash and Cash Equivalent, Current
us-gaap:RestrictedCashCurrent · last filed 2024-03-18
- 2023-06-30: Restricted Cash, Current $541.18K.
- 2023-03-31: Restricted Cash, Current $541.18K.
- 2022-12-31: Restricted Cash, Current $541.18K.
- 2022-09-30: Restricted Cash, Current $541.18K.
| Period end | Restricted Cash, Current |
|---|---|
| 2023-06-30 | $541.18K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $541.18K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $541.18K 10-K · filed 2024-03-18 |
| 2022-09-30 | $541.18K 10-Q · filed 2022-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |